The rate of liver cirrhosis is about 40% to 75% among patients with hepatocellular carcinoma
(HCC). Therefore, many patients with HCC were with low serum albumin before and after
(especially) hepatic resection. Serum albumin level has been routinely used in clinical
practice as a surrogate marker to evaluate nutritional status and liver function. Serum
albumin concentration is used as an independent mortality risk predictor in a broad range of
clinical and research settings. However, the role of albumin infusion in patients with
hepatocellular carcinoma (HCC) after resection is unknown. The present study aimed to
investigate the safety and clinical necessity of albumin infusion for HCC patients after
hepatic resection.